Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer

Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer

Introduction: Neoadjuvant therapy constitutes a valuable modality for diminishing tumor volume prior to surgical resection. Nonetheless, its application encounters limitations in the context of recurrent tumors, which manifest resistance to conventional treatments. Silver nanoparticles (AgNPs) have...

ver descrição completa

Detalhes bibliográficos
Principais autores: Moisés Armides Franco Molina, David Reding Hernández, Paola Leonor García Coronado, Jorge R. Kawas, Diana G. Zárate Triviño, Sara Paola Hernández Martínez, Beatriz Elena Castro Valenzuela, Cristina Rodríguez Padilla
Formato: Artigo
Idioma:English
Publicado em: Frontiers Media S.A. 2024-01-01
coleção:Frontiers in Pharmacology
Assuntos:
neoadjuvant
tumor relapse and recurrence
silver nanoparticles
breast cancer
breast cancer relapse
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2023.1332439/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1332439/full

Registros relacionados